Time to rethink the role of sodium-glucose co-transporter 2 inhibitors in the elderly. Authors' reply

Pol Arch Intern Med. 2019 Feb 28;129(2):143-144. doi: 10.20452/pamw.4470. Epub 2019 Feb 28.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aged
  • Diabetes Mellitus, Type 2*
  • Glucose
  • Humans
  • Long-Term Care
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Sodium
  • Glucose